LV8 / Lot 2604-ELive
Tirzepatide
Dual GIP/GLP-1 Research Compound
C₂₂₅H₃₄₈N₄₈O₆₈
In stockLot 2604-E
Tirzepatide
Dual GIP/GLP-1 Research Compound · CAS 2023788-19-2
$249.00
10mg · lyophilized
99.3%
HPLC Verified
Quantity
1
Volume savings10% off applied
10%
$150+
15%
$300+
20%
$500+
Add $51.00 to unlock 15% off.
Free shipping unlocked
Buy 2 get 1 free · Buy 3 get 1 free — auto-applied at checkout
$249.00 you save $24.90
03 / Research Notes
About Tirzepatide.
A synthetic dual-agonist peptide engineered to bind GIP and GLP-1 receptors. For research use into multi-pathway metabolic regulation.
All material supplied for research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
What you receive
- ◆1 × sealed vial — 10mg lyophilized Tirzepatide
- ◆Tamper-evident pharma-grade packaging
- ◆Batch-specific COA (also available online)
- ◆Cold-chain ice pack shipping with tracking
- ◆Reconstitution & storage guidance card
01 / Technical Specifications
The full sheet.
- CAS Number
- CAS 2023788-19-2
- Molecular formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular weight
- 4813.45 g/mol
- Form
- Lyophilized powder
- Category
- Metabolic
- Net weight
- 10mg
- Purity (HPLC)
- 99.3%
- Endotoxin
- <0.1 EU/mg
- Lot number
- 2604-E
- Tested
- April 16, 2026
- Reconstitution
- Bacteriostatic water
- Storage
- Lyophilized: −20°C. Reconstituted: 2–8°C, use within 28 days.
02 / Certificate of Analysis
Every batch verified.
Third-party HPLC and mass spectrometry on every lot. The full COA for this batch is below, with peak chromatogram and signed lab report.
Certificate of Analysis
LV8-2604-E
VERIFIED
CompoundTirzepatide
Test methodRP-HPLC, 220nm
Purity99.3%
Mass specPASS · confirmed
Endotoxin<0.1 EU/mg
TestedApril 16, 2026
LabJanoschek Analytical
04 / Researchers also chose